Weight Loss Drugs Improve Heart Health Regardless of Amount of Weight Lost

Translate to Spanish or other 102 languages!

A new study finds that GLP-1 drugs’ heart health benefits may not be solely due to weight loss. Image for illustration purposes
A new study finds that GLP-1 drugs’ heart health benefits may not be solely due to weight loss. Image for illustration purposes
- Advertisement -

As the popularity of glucagon-like peptide-1 (GLP-1) receptor agonists Trusted Source for weight loss — such as Wegovy and Zepbound — continues to grow, researchers continue to examine how these medications might impact other areas of a person’s health.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/weight-loss-drug-helps-heart-regardless-of-amount-of-weight-lost?utm_term=feedcontent&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-10-28&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recertified for Advanced Hip & Knee Replacements

DHR Health has once again earned The Joint Commission's Advanced Certification in Total Hip and Total Knee Replacement, reaffirming its commitment to providing high-quality, patient-centered orthopedic care to the Rio Grande Valley.

STHS Named to Newsweek’s America’s Greatest Midsize Workplaces for Women

The American workforce is more diverse than ever, with women helping lead that transformation. 

Study Points to High Blood Pressure as a Key Factor in Rising Heart Disease Rates

Heart disease is the leading cause of death in the United States according to the Journal of the American College of Cardiology. Its impact extends beyond biology, with social detriments such as food insecurity, socioeconomic status and education influencing outcomes.

Dysfunctional, Not Missing, Immune Cells Explain Skin Cancer Risk in Immunosuppressed Patients

Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those cells – known as macrophages – have lost the ability to communicate effectively.
- Advertisement -